DOCSLIB.ORG

WO 2017/091764 Al 1 June 2017 (01.06.2017) W P O P C T

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2017/091764 Al 1 June 2017 (01.06.2017) W P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/352 (2006.01) A61K 31/192 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, PCT/US2016/063662 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 23 November 2016 (23.1 1.2016) KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: ZW. 62/259,549 24 November 2015 (24. 11.2015) US (84) Designated States (unless otherwise indicated, for every (71) Applicant: CONSTANCE THERAPEUTICS, INC. kind of regional protection available): ARIPO (BW, GH, [US/US]; 506 Tremont Avenue, Point Richmond, Califor GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, nia 94801 (US). TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, (72) Inventors: FINLEY, Constance; c/o Constance Thera DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, peutics, Inc., 506 Tremont Avenue, Point Richmond, Cali LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, fornia 94801 (US). BESTWICK, Haley Poole; c/o Con SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, stance Therapeutics, Inc., 506 Tremont Avenue, Point GW, KM, ML, MR, NE, SN, TD, TG). Richmond, California 94801 (US). Published: (74) Agents: PRESLEY, Andrew D . et al; Kilpatrick Town- send and Stockton LLP, Two Embarcadero Center, Suite — with international search report (Art. 21(3)) 1900, San Francisco, California 941 11 (US). (54) Title: CANNABIS OIL COMPOSITIONS AND METHODS FOR PREPARATION THEREOF MCF-7 FIG. 10A (57) Abstract: The present invention provides cannabis oil compositions, including cannabis oil compositions containing vitamin E, and methods for preparing the cannabis oil compositions. In some embodiments, the invention provides a method for preparing a cannabis oil composition comprising eluting cannabinoids from cannabis plant material with a solvent to produce an eluate; filtering the eluate with a filter to produce a filtrate; evaporating the solvent from the filtrate with a distiller to produce a distillate; and pur ging the distillate under conditions sufficient to remove residual solvent. In some embodiments, the method further includes mixing a quantity of vitamin E with the extract. Blended cannabis oil compositions containing mixtures of cannabis oil preparations are also described. CANNABIS OIL COMPOSITIONS AND METHODS FOR PREPARATION THEREOF CROSS-REFERENCES TO RELATED APPLICATIONS [0001] The present application claims priority to U.S. Provisional Pat. Appl. No. 62/259,549, filed on November 24, 2015, which application is incorporated herein by reference in its entirety for all purposes. FIELD OF TECHNOLOGY [0002] This disclosure relates generally to cannabis oils and cannabis oil formulations, including cannabis oil compositions with vitamin E, and methods of preparation thereof. BACKGROUND OF THE INVENTION [0003] The medicinal use of oils and extracts derived from cannabis plant material has been growing in popularity. For example, pharmacologically active compounds in cannabis plant material including, but not limited to, delta-9-tetrahydrocannabinol (or THC) and cannabidiol (CBD) have been shown to reduce the effects of nausea and vomiting caused by certain chemotherapy treatments. Research has also shown the ability of cannabinoids and other compounds found in cannabis to stimulate bone growth, relieve pain, aid sleep, inhibit bacterial cell growth, inhibit cancer cell growth, and alleviate or otherwise reduce the symptoms of cancer, epilepsy, autoimmune disease, neurodegeneration, Alzheimer's disease, Lyme disease, post-traumatic stress disorder, and inflammation. Furthermore, extracts of cannabis plant material, whether ingested or inhaled, have also been shown to have therapeutic effects in patients with glaucoma, dysmenorrhea, migraines, anxiety disorders, or a combination thereof. [0004] However, cannabis oil is often highly viscous, making it difficult to work with and load into new delivery devices such as vaporizers and E-cigarettes. In addition, such oils, when vaporized or smoked, are often rough on a patient's throat and may induce coughing or gagging. [0005] Therefore, a solution is needed in order to make such extracts more conducive to today's delivery devices and make the inhalation/consumption of such extracts more palatable for patients. In addition, such a solution should also not have an adverse effect on the potency of the extract's active compounds and preserve the extract's gustatory or aromatic qualities. BRIEF SUMMARY OF THE INVENTION [0006] Disclosed herein are cannabis oil extracts, compositions containing blended mixtures of the extracts, and methods for preparing the extracts and compositions. In particular, a method is disclosed for preparing a cannabis oil composition comprising eluting cannabinoids from cannabis plant material with a solvent to produce an eluate, filtering the eluate with a filter to produce a filtrate, evaporating the solvent from the filtrate with a distiller to produce a distillate, and dehydrating/purging the distillate with a dehydrator or vacuum oven to produce an extract. In some embodiments, the method further includes mixing a quantity of vitamin E with the extract. In some embodiments, the quantity of vitamin E is sufficient to reduce the viscosity of the composition to less than 3500 cP. In some embodiments, the method includes eluting cannabinoids and terpenes from cannabis plant material to produce the eluate. In some embodiments, the method includes mixing the extract with essential oils. [0007] In certain embodiments, the invention provides a composition comprising a first cannabis oil preparation having a first cannabinoid profile and a second cannabis oil preparation having a second cannabinoid profile. In some embodiments, the composition comprises ∆ -tetrahydrocannabinol (THC) and (-)-cannabidiol (CBD). In some embodiments, the ratio of THC to CBD ranges from about 20: 1 to about 1:20 by weight. In some embodiments, the ratio of THC to CBD is about 4 :1 by weight. In some embodiments, the composition comprises one or more additional cannabis oils having additional cannabinoid profiles. [0008] The methods and compositions disclosed herein may be implemented in any means for achieving various aspects. Other features will be apparent from the accompanying drawings and from the detailed description that follows. BRIEF DESCRIPTION OF THE DRAWINGS [0009] Exemplary embodiments are illustrated by way of example and are not limited to the figures of the accompanying drawings, in which, like references indicate similar elements. [0010] Fig. 1A shows a method of preparing a cannabis oil composition according to one embodiment of the invention. [0011] Fig. IB shows a method of preparing a cannabis oil composition according to an embodiment of the invention including optional decarboxylation and filtration steps. [0012] Fig. 2 shows a graph depicting the viscosities of cannabis oil compositions as a function of vitamin E percentages in the cannabis oil compositions. [0013] Fig. 3 is a graph depicting THC and CBD percentages in cannabis oil compositions made from various strains of cannabis plant material. [0014] Fig. 4A shows the growth of SF-268 brain cancer cells in the presence of blended cannabis oil compositions and single-strain cannabis oil compositions. [0015] Fig. 4B shows the growth of SF-268 brain cancer cells in the presence THC and CBD at concentrations equal to the concentration in blended cannabis oil compositions and single-strain cannabis oil compositions. [0016] Fig. 4C shows the growth of SF-268 brain cancer cells in the presence of isolated cannabinoids. [0017] Fig. 5A shows the growth of SF-295 brain cancer cells in the presence of blended cannabis oil compositions and single-strain cannabis oil compositions. [0018] Fig. 5B shows the growth of SF-295 brain cancer cells in the presence THC and CBD at concentrations equal to the concentration in blended cannabis oil compositions and single-strain cannabis oil compositions. [0019] Fig. 5C shows the growth of SF-295 brain cancer cells in the presence of isolated cannabinoids. [0020] Fig. 6A shows the growth of SF-539 brain cancer cells in the presence of blended cannabis oil compositions and single-strain cannabis oil compositions. [0021] Fig. 6B shows the growth of SF-539 brain cancer cells in the presence THC and CBD at concentrations equal to the concentration in blended cannabis oil compositions and single-strain cannabis oil compositions. [0022] Fig. 6C shows the growth of SF-539 brain cancer cells in the presence of isolated cannabinoids. [0023] Fig. 7A shows the growth of SNB-19 brain cancer cells in the presence of blended cannabis oil compositions and single-strain cannabis oil compositions. [0024] Fig. 7B shows the growth of SNB-19 brain cancer cells in the presence THC and CBD at concentrations equal to the concentration in blended cannabis oil compositions and single-strain cannabis oil compositions. [0025] Fig. 7C shows the growth of SNB-19 brain cancer cells in the presence of isolated cannabinoids. [0026] Fig. 8A shows the growth of SNB-75 brain cancer cells in the presence of blended cannabis oil compositions and single-strain cannabis oil compositions.
Recommended publications
  • My Index Expurgatorius Would Run Much As Follows

    My Index Expurgatorius Would Run Much As Follows

    their union, so must the united Pharmacopaeias set an example The number of alkaloids and other active principles of plants of self-abnegation. should be increased. Aconitia, of which a certain mode of Thus, as a melancholy indispensable in our new pharmaceutical preparation has been published, should not have been omitted reform bill, I beg to present a list of rotten boroughs for dis- from the last London Pharmacopoeia. The principles of conium, franchisement-a catalogue of drugs drawn from the materia hyoscyamus, tobacco, lobelia, and other active drugs, might be medica of the three Pharmacopoeias whose constituencies, or retained in greater safety if combined with an acid, such as the doctors who prescribe them, have become so extremely sulphuric, which renders them very soluble in water. For limited that it seems scarcely necessary to retain them any convenience of prescribing, and the avoidance of mistakes in longer. dispensing such powerful poisons, I would recommend that Index run as standard of one certain of dose should be My Expurgatorius would much follows :- , solutions strength Absinthium, acetum, acidum aceticum (omit eight of these, ordered in the British Pharmacopoeia. Such solutions would and leave only a strong acid of 85 per cent., and a dilute acid be uniform in strength, and more to be depended on for cer- of 5 per cent.), allium, althsea, anethum, angelica, anthemidis tainty and safety of effect than any tincture, juice, infusion, or oleum, aurantii fructus, balsamum Canadense, barytas carb. et extract of the plant, the amount of whose active principle of sulph., calamina (replace by pure carb.
  • Palliative Care : the 400-Year Quest for a Good Death

    Palliative Care : the 400-Year Quest for a Good Death

    Palliative Care This page intentionally left blank Palliative Care The 400-Year Quest for a Good Death Harold Y. Vanderpool McFarland & Company, Inc., Publishers Jefferson, North Carolina ISBN 978-0-7864-9799-7 (softcover : acid free paper) ISBN 978-1-4766-1971-2 (ebook) ♾ LIBRARY OF CONGRESS CATALOGUING DATA ARE AVAILABLE British Library cataloguing data are available © 2015 Harold Y. Vanderpool. All rights reserved No part of this book may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying or recording, or by any information storage and retrieval system, without permission in writing from the publisher. On the cover: clockwise from top left hospice nurse with patient (Stockbyte/Thinkstock); Doctor Onstine, medical doctor, making an examination, 1943 (Library of Congress); Doctor and nurse examining patient in hospital room (Digital Vision/Thinkstock); The doctor’s office on Transylvania Project, Louisiana, 1940 (Library of Congress); Intensive Care Unit (iStock/Thinkstock) Printed in the United States of America McFarland & Company, Inc., Publishers Box 6¡¡, Je›erson, North Carolina 28640 www.mcfarlandpub.com For Jan This page intentionally left blank Table of Contents Acknowledgments ix Preface 1 1: From Proclamation to Recognition: 1605–1772 5 2: Minute Details and Codified Conduct: 1789–1825 23 3: That Science Called Euthanasia: 1826–1854 39 4: Polarities Between Attention and Disregard: 1859–1894 58 5: Challenging the Overreach of Modern Medicine: 1895–1935 76 6: Never Say Die Versus Care for the Dying: 1935–1959 93 7: Times of Momentous Transition: 1960–1981 112 8: Progress, Threatening Seas, and Endurance: 1982–1999 140 9: Choices: 2000 to the Present 173 Epilogue 207 Chapter Notes 211 Bibliography 243 Index 265 vii This page intentionally left blank Acknowledgments Research on the topics in this history began when I wrote the first of two master’s degree theses as a Kennedy fellow in medical ethics and the history of medicine at Har- vard University.
  • Keynotes of the Homoeopathic Materia Medica Dr. Adolph VON

    Keynotes of the Homoeopathic Materia Medica Dr. Adolph VON

    KKeeyynnootteess ooff TThhee HHoommooeeooppaatthhiicc MMaatteerriiaa MMeeddiiccaa DDrr.. AAddoollpphh VVOONN LLIIPPPPEE Aconitum Napellus. Agaricus Muscarius. Agnus Castus. Allium Cepa. Aloe. Alumina. Ambra Grisea. Ammonium Carbonicum. Ammonium Muriaticum. Anacardium. Angustura. Antimonium Crudum. Antimonium Tartaricum Apis Mellifica. Argentum Metallicum. Arnica Montana. Arsenic Album. Arsenic Metallicum. Asafoetida. Asarum Europaeum. Aurum Metallicum. Baryta Carbonica. Belladonna. Bismuth. Borax. Bovista. Bromium. Bryonia Alba. Caladium Seguinum. Calcarea Ostrearum. Camphora. Cannabis Sativa. Cantharides. Capsicum. Carbo Animalis. Carbo Vegetablis. Cascarilla. Castoreum. Causticum. Chamomilla. Chelidonium Majus. Cicuta Virosa. China. Cina. Cinnamonum. Cinnabaris. Clematis Erecta. Cocculus. Coffee Cruda. Colchicum. Colocynthis. Conium Maculatum. Corallium Rubrum. Crocus Sativus. Croton Tiglium. Cuprum Metallicum. Cyclamen. Daphne Mezereum. Digitalis Purpurea. Drosera. Dulcamara. Euphorbia. Euphrasia. Ferrum Metallicum. Graphites. Guajacum. Helleborus Niger. Hepar Sulphuris Calcareum. Hyoscyamus Niger. Ignatia Amara. Iodum. Ipecacuanha. Kali Carbonicum. Kali Nitrium. Laurocerasus. Ledum Palustre. Lycopodium Clavatum. Magnesia Carbonica. Manganum. Menyanthes. Mercurius Sublimatus. Mercurius Solubilis Hahnemanni. Mezereum Daphne. Moschus. Muraticum Acidum. Natrum Carbonicum. Natrum Muriaticum. Nitric Acidum. Nux Moschata. Oleander. Opium. Paris Quadrifolia. Phosphoric acid. Phosphorus. Platina. Plumbum. Ranunculus Bulbosus. Ranunculus Scleratus.
  • Confessions of an American Opium Eater : from Bondage to Freedom

    Confessions of an American Opium Eater : from Bondage to Freedom

    Cornell University Library The original of tiiis book is in the Cornell University Library. There are no known copyright restrictions in the United States on the use of the text. http://www.archive.org/details/cu31924090935077 In compliance with current copyright law, Cornell University Library produced this replacement volume on paper that meets the ANSI Standard Z39.48-1992 to replace the irreparably deteriorated original. 2001 GforttcU Uttlnetaitg ffiibrarg Stljaftt, !N*ni lock CHARLES WILUAM WASON COLLECTION CHINA aWD THE CHINESE THE GIFT OF CHARLES WILLIAM WASON CLASS OF 1876 laiB ''^.^^^-^ ) : Confessions American Opium Eater From Bondage to Freedom Timely advised, the coming evil shun Better not do the deed than weep it done. — Trior. BOSTON James H. Earle 178 Washington Street 1895 Copyright, i8gS, By James H. Earle. Ail rights reserved. OOI^TEZSTTS. CHAPTER I. Preliminary i CHAPTER II. Concerning My Early Life lo CHAPTER III. My First Experiment with Opium 24 CHAPTER IV. Am I My Sister's Keeper ?—The Prodigal Daughter ... 33 CHAPTER V. At the Gaming Table — The Death of My Wife .... 41 CHAPTER VI. I Attempt to Break Away from the Opium Habit, Do not Suc- ceed, and Return to Gambling 47 CHAPTER VII. "Who Fell Among Thieves"—A Startling Experience . 51 CHAPTER VIII. I Enter the Maine General Hospital as a Patient ... 56 CHAPTER IX. I Attempt to Fight the Demon Morphia Single-Handed and Am Defeated 63 II OOlTTEilsrT'S. (COHTISUEDA CHAPTER X. A Dishonorable Lawyer — I Advocate My Own Case . 73 CHAPTER XI. How I Was Living . .... 78 CHAPTER XII. I Believe in God and Christ, but Have No Religion .
  • Wild Lettuce (Lactuca Virosa) Toxicity Sima Besharat,1,2 Mahsa Besharat,3 and Ali Jabbari4

    Wild Lettuce (Lactuca Virosa) Toxicity Sima Besharat,1,2 Mahsa Besharat,3 and Ali Jabbari4

    BMJ Case Rep. 2009; 2009: bcr06.2008.0134. Published online 2009 Apr 28. doi: 10.1136/bcr.06.2008.0134 PMCID: PMC3031874 Other full case Wild lettuce (Lactuca virosa) toxicity Sima Besharat,1,2 Mahsa Besharat,3 and Ali Jabbari4 Sima Besharat, Email: moc.oohay@pg_tarahseb_s Copyright 2009 BMJ Publishing Group Ltd Abstract BACKGROUND Iran grows a variety of herbs, some of which are processed for pharmaceutical purposes.1 Wild lettuce (fig 1), which is known as “Laitue vireuse” in French, “Wilder lattich” in German and “Allubbyne” in Arabic, is also known as “opium lettuce”. Its scientific name is Lactuca virosa; in Latin, lactuca means “milky extract” and virosa means “toxic”.2 A biennial herb, wild lettuce grows on the banks of rivers and on waste grounds to a maximum height of 6 feet, flowering in July and August.1 It has a smooth and light green, sometimes purple spotted, erect stem which springs from a brown tap root.2 It is cultivated in different regions of the world, such as Austria, France, Germany, Scotland and Iran.1 The whole plant is rich in a milky juice that flows freely when it is scratched. The juice has a bitter taste and a noxious odour. When dried, it hardens, turns brown, and is known as lactucarium. L virosa has been found to contain lactucic acid, lactucopicrin which is amorphous, 50–60% lactucerin (lactucone) and lactucin. Lactocerine is the main component of the lactucarium, which is a neutral insoluble material.1 Lactucarium is a diuretic, laxative and sedative agent which relieves dyspnoea, and decreases gastrointestinal inflammation and uterus contractions.
  • Medical Science of Milk Included in Celsus' Treatise De Medicina

    Medical Science of Milk Included in Celsus' Treatise De Medicina

    Studia Ceranea 6, 2016, p. 323–353 ISSN: 2084-140X DOI: 10.18778/2084-140X.06.17 e-ISSN: 2449-8378 Maciej Kokoszko (Łódź) Jolanta Dybała (Piotrków Trybunalski) Medical Science of Milk Included in Celsus’ Treatise De medicina ilk has always been a very significant food product in the Mediterranean1 M(but also in other regions of the ancient world2). Thus, it comes as no sur- prise that ancient and Byzantine physicians devoted their research to this subject3. It is commonly believed that fresh milk was quite rare in everyday diet of those times, whereas its derivative – namely cheese – was consumed much more fre- quently. This general production-consumption pattern survived the Antiquity and was equally characteristic of the early Middle Ages4. 1 For the areas initially untouched by the Greek culture, and later by the Roman culture, cf. E. Bres- ciani, Nourritures et boissons de l’Égypte ancienne, [in:] Histoire de l’alimentation, ed. J.-L. Flan- drin, M. Montanari, Paris 1996, p. 63, 65, 67; J. Soler, Les raisons de la Bible: règles alimentaires hébraïques, [in:] Histoire…, p. 73–74, 79; A. Spanò Giammellaro, Les Phéniciens et les Carthaginois, [in:] Histoire…, p. 91, 96 etc. For the Greco-Roman area of the Mediterranean basin, cf. M.-C. Amo- uretti, Villes et campagnes grecques, [in:] Histoire…, p. 138, 143; J.P. Alcock, Milk and its Products in Ancient Rome, [in:] Milk. Beyond the Dairy. Proceedings of the Oxford Symposium on Food and Cookery 1999, ed. H. Walker, Totnes 2000, p. 31–38; C.A. Déry, Milk and Dairy Products in the Ro- man Period, [in:] Milk…, p.
  • Plant Powers, Poisons, and Herb Craft

    Plant Powers, Poisons, and Herb Craft

    PLANT POWERS, POISONS, AND HERB CRAFT BY DALE PENDELL Foreword by Gary Snyde, $21.95 US In 'Pharmako/Poeia, Dale Pendell offers a mesmerizing guide to psychoactive Alternative plants, from their pharmacological roots to the literary offshoots. "This is a Health/ book," writes Gary Snyder, "about danger: dangerous knowledge, even more Literature dangerous ignorance." Against the greater danger, ignorance, Pendell strikes a formidable blow, as he proves himself a wise and witty guide to our plant teach- ers, their powers and their poisons. "Dale Pendell reactivates the ancient connection between the bardic poet and the shaman. His Pharmako/Poeia is a litany to the secret plant allies that have always accompanied us along the alchemical trajectory that leads to a new and yet authentically archaic future." — Terence McKenna, author of True Hallucinations "Much of our life-force calls upon the plant world for support, in medicines and in foods, as both allies and teachers. Pendell provides a beautifully crafted bridge between these two worlds. The magic he shares is that the voices are spoken and heard both ways; we communicate with plants and they with us. This book is a moving and poetic presentation of this dialogue." — Dr. Alexander T. Shulgin, University of California at Berkeley, Department of Public Health "Pharmako/Poeia is an epic poem on plant humours, an abstruse alchemic treatise, an experiential narrative jigsaw puzzle, a hip and learned wild-nature reference text, a comic paean to cosmic consciousness, an ecological handbook, a dried-herb pastiche, a countercultural encyclopedia of ancient fact and lore that cuts through the present 'conservative' war-on-drugs psychobabble." - Allen Ginsberg, poet Cover design "Dale PendelFs remarkable book will make it impossible to and color work ever again underestimate the most unprepossessing plant.
  • Wild Lettuce Latin Name: Lactuca Virosa

    Wild Lettuce Latin Name: Lactuca Virosa

    Wild Lettuce Latin Name: Lactuca virosa Also known as: Prickly Lettuce, Horse Thistle, Green Endive, Compass Plant, Poor Man’s Opium, Opium Lettuce Scientific Classification Wild varieties of lettuce have some percentage of narcotic sap (induces sleep or stupor and relieves pain without the addictive qualities of opiates) and among them Lactuca virosa has the greatest concentration of narcotic juice. Other medicinal varieties of lettuce include L. scariola (also commonly known as prickly lettuce) L. altissima, L. Canadensis (also called wild lettuce and commonly found in America) and L. sativa (known as garden lettuce). Cultivation of garden lettuce has significantly reduced the narcotic sap content, but the herb is still used as an ingredient for lotions to heal skin disorders caused by sunburn and coarseness. Family: Asteraceae – aster, daisy and sunflower family Compositae – in earlier classifications Genus: Lactuca – lettuce Species: L. virosa – bitter lettuce Influence on the Body (PRINCIPLE ACTIONS are listed in CAPITAL LETTERS) Blood & Circulation heart palpitations Body System LOOSENS CATARRH (inflamed and congested mucous membranes) • HARDENED MUCUS Digestive Tract bitter (stimulates digestive juices and improves appetite) • dyspepsia (indigestion) • colic (severe abdominal pain) • irritated gastro-intestinal tract • diarrhea • intestinal worms Eyes eyesight Infections and ERRATIC FEVER • diaphoretic (promotes perspiration) Immune System • Candida albicans (yeast infection) • whooping cough (also known as pertusis, a contagious
  • Medical Books in the Byzantine World

    Medical Books in the Byzantine World

    EIKASMOS Quaderni Bolognesi di Filologia Classica Studi Online, 2 MEDICAL BOOKS IN THE BYZANTINE WORLD EDITED BY BARBARA ZIPSER BOLOGNA 2013 Medical books in the Byzantine world edited by BarbaraZipser Bologna 2013 o Eikasmós Online II ISSN 2282-2178 In memoriam David Bennett y Table of Contents Acknowledgments . vii List of figures. .xi List of abbreviations . xii 1. Prefatory note: the uses of medical manuscripts Peregrine Horden (RHUL and Oxford). .1 2. Byzantine medicine, genres, and the ravages of time Vivian Nutton (UCL) . 7 3. Disease and where to treat it: a Byzantine vade mecum Dionysios Stathakopoulos (KCL) . 19 4. Two Latin Pre-Salernitan medical manuals, the Liber passionalis and the Tereoperica (Ps. Petroncellus) Klaus-Dietrich Fischer (Mainz) . 35 5. The fate of a Greek medical handbook in the Medieval West: the Intro- duction, or the Physician ascribed to Galen Caroline Petit (ICS) . 57 6. Aristotle and the Caliph's Dream. Aspects of medical translations David Bennett (formerly NHS and RHUL) . 79 7. `Syriac' plant names in a fifteenth century Greek glossary (From the Wellcome Library Books and Manuscripts) Nikolaj Serikoff (Wellcome Library). .97 8. The Reception of Galen's Art of medicine in the Syriac Book of medicines Siam Bhayro (Exeter) . 123 9. Medieval hospital formularies: Byzantium and Islam compared Peregrine Horden (RHUL and Oxford) . 145 10. Cancerous cells, Neanderthal DNA and the tradition of Byzantine me- dicine. Textual criticism in philology and genomics Florian Markowetz (Cancer Research UK Cambridge and University of Cambridge) and Barbara Zipser (RHUL) . 165 Acknowledgements This volume originates from a conference on Byzantine Medical Manuals in Context, held in central London on the 19th of September 2009.
  • 03/11/2020 Time: 09:00 AM Location: 229 Committee: Senate Commerce, Consumer Protection, and Health Senate Education

    03/11/2020 Time: 09:00 AM Location: 229 Committee: Senate Commerce, Consumer Protection, and Health Senate Education

    DAVID Y. IGE DR. CHRISTINA M. KISHIMOTO GOVERNOR SUPERINTENDENT STATE OF HAWAI`I DEPARTMENT OF EDUCATION P.O. BOX 2360 HONOLULU, HAWAI`I 96804 Date: 03/11/2020 Time: 09:00 AM Location: 229 Committee: Senate Commerce, Consumer Protection, and Health Senate Education Department: Education Person Testifying: Dr. Christina M. Kishimoto, Superintendent of Education Title of Bill: HB 2457, HD2 RELATING TO THE YOUTH VAPING EPIDEMIC. Purpose of Bill: Beginning 1/1/2021: bans the sale of flavored tobacco products; prohibits mislabeling of e-liquid products containing nicotine; and establishes fines and penalties for violations. Requires the Department of Education to establish a safe harbor program by which persons under 21 years of age may dispose of electronic smoking devices in their possession. Requires public school teachers and educators to confiscate electronic smoking devices. Increases fines for the purchase or possession of tobacco products and electronic smoking devices by persons under 21 years of age. Authorizes a court to impose, as a penalty on a person 18-21 years of age who is convicted of possession of a tobacco product or electronic smoking device, the requirement to complete a tobacco education program, complete a tobacco use cessation program, or perform community service instead of paying a fine. Effective 7/1/2050. (HD1) Department's Position: The Department of Education (Department) appreciates the intent and offers comments on HB 2457, HD2. There is a zero-tolerance for tobacco products and electronic smoking devices (ESDs) on the Department’s campuses, transportation, and/or during Department school-sponsored activities. The Department is working in partnership with the Hawaii Department of Health (DOH) to educate youth to make positive health decisions.
  • Price List Is Updated Daily

    Price List Is Updated Daily

    Disclaimer: This price list is updated daily. Eden Botanicals, LLC Please see our website for the most current information. 3820 Cypress Dr. #12 Petaluma, CA 94954 USA Distilled Essential Oils · Expresed Citrus Oils www.edenbotanicals.com Absolutes - CO2 Extracts · Organic Extracts (Extraits) [email protected] Wildcrafted Essential Oils & Extracts · Rare & Precious Oils Organic Essential Oils · Organic CO2 Extracts · Dilutions Toll Free 1-855-EDENOIL Antioxidants · Carrier Oils · Essence Blends Tel 1-707-509-0041 Containers · Accessories Fax 1-707-949-2526 Eden Botanicals Catalog - Page 1 Updated Sep 24, 2021 COMMON NAME ITEM SAMPLE 5 10 15 ML 30 ML 2 4 8 16 1 (Scientific Name) CODE VIAL ML ML (1/2 OZ) (1 OZ) OZ OZ OZ OZ KG NEWLY ADDED HAS ORIFICE REDUCER IS TINY AGARWOOD 57 $12 $169 / $404 $711 $1,265 $2,299 / / / (Aquilaria crassna) Steam Distilled Essential Oil Use: Aromatherapy/Natural Perfumery/Incense. Rich and complex, sweet, warm, deep, precious woody aroma, shades of smoky, amber-y Origin: Vietnam incense and honeyed tobacco, and animalic notes of musk/castoreum - in a word, amazing! AGARWOOD - 5% 58 $3 $14 / $33 $57 $100 $178 $320 $580 $1,167 (Aquilaria crassna) Steam Distilled Essential Oil Use: Aromatherapy/Natural Perfumery/Incense. Rich and complex, sweet, warm, deep, precious woody aroma, shades of smoky, amber-y Origin: Vietnam incense and honeyed tobacco, and animalic notes of musk/castoreum - in a word, amazing! ALMOND, BITTER 59 $3 $20 / $46 $80 $142 $253 $455 / / (Prunus armeniaca L.) Steam Distilled Essential Oil Use: Natural Perfumery. Prussic acid has been removed, making this oil non-toxic for use in perfumery.
  • Chemoreception & Tobacco Leffingwell & a Ssociates

    Chemoreception & Tobacco Leffingwell & a Ssociates

    Chemoreception & Tobacco John C. Leffingwell Centers for Disease Control and Prevention Leffingwell Leffingwell & Associates October 6, 2014 Aspects of Oral Perception • Taste (Gustation) • Aroma (Olfaction) • Mouthfeel • Thermal & Chemesthetic (e.g. Trigeminal) Cooling Ingredients • Menthol Production • Menthol & Perception • Other Cooling Ingredients Tobacco & Flavoring • The Old Cigarette Companies • The Changing Cigarette • Filters - Lower Tar & Nicotine • Smoke pH, Ammonia & DAP • Tobacco Flavors E-Cigarettes & Flavors Leffingwell Leffingwell & Associates • The New Wild West Leffingwell & Associates ASPECTS OF ORAL PERCEPTION ORAL ASPECTSOF ASPECTS OF ORAL PERCEPTION Taste Umami Sweet (MSG) (Sugars) Taste (Gustation) Sour Bitter (Citric (Quinine) acid) Salty (NaCl) Leffingwell Leffingwell & Associates And is “Kokumi” the sixth taste? ASPECTS OF ORAL PERCEPTION Almond, Peanut, Pine, Amber Walnut, Hazelnut Patchouli Bell pepper, Peas, Carrot, Hay, Mushroom, Moldy Grass, Tobacco, Nutty Woody Corky, Geosmin Mint Herbal Earthy Citrus, Berry, Fig, Vegetable Raisin, Cherry, Plastic, Apple, Banana, Gasoline, Melon Solventy Fruity Chemical Clove, Nutmeg, Aroma Vinegar, Cinnamon, Anise, Spicy Pungent Basil, Coriander, Mustard, (Olfaction) Horseradish Black pepper Phenolic Floral Magnolia, Rose, Smoky, Orange blossom, Leather, Violet, Geranium Micro- Vanilla, Roasted biological Medicinal Yeasty, Buttery, Putrid Animal Cocoa, Sweaty, Horsey, Coffee, Mousey Meat Leffingwell Leffingwell & Associates Fecal Musk, Castoreum ASPECTS OF ORAL PERCEPTION